Tumori 2013-01-01

A case report of a patient with advanced acinar cell carcinoma of the pancreas: long-term survival with regional, systemic and targeted therapy.

Celina Ang, Luis A Herran, Diane Reidy Lagunes, David S Klimstra, Nancy E Kemeny

Index: Tumori 99(2) , e61-4, (2013)

Full Text: HTML

Abstract

Acinar cell carcinoma of the pancreas is an uncommon malignancy for which there are no prospective, randomized data to guide therapy. We describe the clinical course and management of a patient with advanced pancreatic acinar cell carcinoma who is alive seven years after diagnosis using systemic and regional chemotherapies as well as molecularly targeted agents.

Related Compounds

Related Articles:

18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.

2014-02-22

[Lancet 383(9918) , 705-13, (2014)]

11C-acetate PET/CT for metabolic characterization of multiple myeloma: a comparative study with 18F-FDG PET/CT.

2014-05-01

[J. Nucl. Med. 55(5) , 749-52, (2014)]

PET/CT with 18F-FDG- and 18F-FBEM-labeled leukocytes for metabolic activity and leukocyte recruitment monitoring in a mouse model of pulmonary fibrosis.

2015-01-01

[J. Nucl. Med. 56(1) , 127-32, (2015)]

The [18F]FDG μPET readout of a brain activation model to evaluate the metabotropic glutamate receptor 2 positive allosteric modulator JNJ-42153605.

2014-08-01

[J. Pharmacol. Exp. Ther. 350(2) , 375-86, (2014)]

FDG-PET scan in assessing lymphomas and the application of Deauville Criteria.

2013-06-01

[J. Pak. Med. Assoc. 63(6) , 725-30, (2013)]

More Articles...